AXLA — Axcella Health Cashflow Statement
0.000.00%
Last trade - 00:00- $1.18m
- -$7.70m
Annual cashflow statement for Axcella Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -36.1 | -59 | -56.5 | -64.6 | -81.2 |
| Depreciation | |||||
| Non-Cash Items | 3.29 | 6.41 | 7 | 7.78 | 8.02 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1 | 0.999 | -0.658 | 2.34 | 3.16 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -30.7 | -51 | -49.8 | -54.2 | -69.6 |
| Capital Expenditures | -0.659 | -0.136 | -0.239 | -0.275 | -0.426 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.073 | 0.019 | -35.9 | 3.32 | 31.3 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.586 | -0.117 | -36.1 | 3.05 | 30.9 |
| Financing Cash Flow Items | -0.959 | -1.22 | -0.039 | -1.73 | -1.19 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 63.9 | 63.7 | 65.4 | 3.16 | 32.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 32.6 | 12.6 | -20.5 | -48 | -6.43 |